IL6 and cancer: Studies on the role of EVs in angiogenesis have demonstrated that cancer cell-derived EVs contain interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), potent pro-angiogenic factors that enhance endothelial cell invasion and organization in tubule-like structures (131).